Alabama Neurology Associates

Birmingham, Alabama 35209

2 studies enrolling now · 6 studies all time

What they study most

Multiple Sclerosis, Multiple Sclerosis (MS), Multiple Sclerosis Spasticity, Relapsing Remitting Multiple Sclerosis, Relapsing-remitting Multiple Sclerosis

Studies at this site

• A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy — Recruiting now
• A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity — Recruiting now
• The MS-LINK™ Outcomes Study — Completed
• Next-Gen MS: Feed-forward PRO Data for MS Research — Stopped early
• Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif® — Completed
• A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis — Status unconfirmed